Publicaciones (101) Publicaciones de LUIS JAVIER MARTÍNEZ GONZÁLEZ

2024

  1. Exploring the role of genetic variability and exposure to bisphenols and parabens on excess body weight in Spanish children

    Ecotoxicology and Environmental Safety, Vol. 286

  2. Exposure to environmental pollutants and genetic variants related to oxidative stress and xenobiotic metabolism—Association with prostate cancer

    Environmental Toxicology and Pharmacology, Vol. 108

  3. Identification of SYNJ1 in a Complex Case of Juvenile Parkinsonism Using a Multiomics Approach

    International Journal of Molecular Sciences, Vol. 25, Núm. 17

  4. Influence of Genetic Polymorphisms on Cognitive Function According to Dietary Exposure to Bisphenols in a Sample of Spanish Schoolchildren

    Nutrients , Vol. 16, Núm. 16

  5. Multi-omic study to unmask genes involved in prostate cancer development in a multi-case family

    Cancer Communications

  6. Mutational landscape of risk variants in comorbid depression and obesity: a next-generation sequencing approach

    Molecular Psychiatry, Vol. 29, Núm. 11, pp. 3553-3566

  7. Targeted next-generation sequencing panel to investigate antiplatelet adverse reactions in acute coronary syndrome patients undergoing percutaneous coronary intervention with stenting

    Thrombosis Research, Vol. 240

  8. The T-cell repertoire of Spanish patients with COVID-19 as a strategy to link T-cell characteristics to the severity of the disease

    Human Genomics, Vol. 18, Núm. 1

2023

  1. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

    The Lancet, Vol. 401, Núm. 10374, pp. 347-356

  2. Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity

    Human Genomics, Vol. 17, Núm. 1

  3. Association of genetic polymorphisms in detoxifying systems and urinary metal(loid) levels with excess body weight among Spanish children: A proof-of-concept study

    Science of the Total Environment, Vol. 873

  4. Explainable artificial intelligence to predict and identify prostate cancer tissue by gene expression

    Computer Methods and Programs in Biomedicine, Vol. 240

  5. Follow-Up Biomarkers in the Evolution of Prostate Cancer, Levels of S100A4 as a Detector in Plasma

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

  6. Genetic Population Flows of Southeast Spain Revealed by STR Analysis

    Genealogy, Vol. 7, Núm. 2

  7. Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome

    Biomedicine and Pharmacotherapy, Vol. 169

  8. Genetic variants of antioxidant and xenobiotic metabolizing enzymes and their association with prostate cancer: A meta-analysis and functional in silico analysis

    Science of the Total Environment, Vol. 898

2022

  1. Assessing the Impact of SARS-CoV-2 Lineages and Mutations on Patient Survival

    Viruses, Vol. 14, Núm. 9

  2. DNA isolation from human remains

    Handbook of DNA Profiling (Springer), pp. 755-771

  3. Determination of exosome mitochondrial dna as a biomarker of renal cancer aggressiveness

    Cancers, Vol. 14, Núm. 1

  4. Differences in maternal and neonatal cardiometabolic markers and placenta status by foetal sex. The GESTAFIT project

    Women's Health, Vol. 18